Mangalam Drugs and Organics logo

Mangalam Drugs and Organics results

NSE: MANGALAMBSE: 532637Pharmaceuticals & BiotechnologySmall Cap

Last close ₹28.65down ₹0.92 (3.11%)BSE ₹28.00

Share price at the NSE close on 23 Oct 2026. Previous close ₹29.57.

52-week range of traded prices to 23 Oct 2026
₹22.80Low, 29 Dec 2025₹71.99High, 23 Oct 2025
Market cap
₹45 Cr3,423rd largest listed
P/E
Lossover the last 12 months
P/B
0.4
Dividend yield
Nonein the last 12 months
ROE
−30.3%
ROCE
−12.9%
Debt to equity
1.02
Volume, NSE
19,55176.4% delivered

Q1 results, quarter to Jun 2026

Standalone: the listed company alone, without its subsidiaries. ₹ crore.Mangalam Drugs and Organics annual results and balance sheet

Revenue
₹57 Cr−0.4% on a year ago · −15.1% on the quarter before
Operating profit
₹0.89 Cr
Net profit
−₹7.55 Cr
Earnings per share
−₹4.77
Operating margin
1.6%
Net margin
−13.2%

From revenue to net profit, ₹ crore

  1. Revenue57
  2. Materials and goods−33
  3. Employee costs−8.8
  4. Other expenses−14
  5. Operating profit0.9
  6. Depreciation−4.0
  7. Other income+0.1
  8. Finance costs−3.7
  9. Profit before tax−6.7
  10. Tax−0.9
  11. Net profit−7.6

Mangalam Drugs and Organics results by quarter

Standalone: the listed company alone, without its subsidiaries. Latest quarter to Jun 2026. Results for the quarter to Sep 2026 are due by 14 Nov 2026, 45 days after it ends.Results filings and date

Revenue and net profit by quarter, ₹ crore

  • Revenue
  • Net profit
  • Loss

Operating and net margin by quarter, per cent

  • Operating margin
  • Net margin
₹ croreSep 2021Q2Filed 18 NovDec 2021Q3Filed 5 FebMar 2022Q4Filed 7 JunJun 2022Q1Filed 16 AugSep 2022Q2Filed 23 NovDec 2022Q3Filed 17 FebMar 2023Q4Filed 31 MayJun 2023Q1Filed 11 AugSep 2023Q2Filed 22 NovDec 2023Q3Filed 24 FebMar 2024Q4Filed 13 JunJun 2024Q1Filed 29 AugSep 2024Q2Filed 15 NovDec 2024Q3Filed 14 FebMar 2025Q4Filed 12 JunJun 2025Q1Filed 19 AugSep 2025Q2Filed 19 FebDec 2025Q3Filed 15 JanMar 2026Q4Filed 14 MayJun 2026Q1Filed 12 Aug
Revenue from operations114941211091086391878297102778089735750586757
1098811199100579191799091687180636252607356
Materials and goods bought8067847474327166516959404151354033374733
Employee costs9912910969109111010101198889
Other expenses2012151617151416191221182019171312151714
Operating profit before depreciation561010860−3271289911−5−3−1−51
Operating margin4.3%6.7%8.4%9.5%7.8%10.2%0.3%−4.0%2.7%7.2%11.4%10.7%10.9%9.9%14.4%−7.9%−5.7%−2.5%−8.0%1.6%
Depreciation and amortisation33333333444444545454
Other income98000000000000000000
Finance costs33343333334443445434
One-off items00000000000000000000
Profit before tax895431−6−10−5041112−13−12−10−13−7
45−2110−1−1−100−2−1021−5001
Tax rate45.3%55.1%−34.4%29.1%28.7%15.4%–––−1,036.6%9.9%−359.2%−124.6%5.4%91.3%–––––
Net profit547320−4−10−4143310−14−7−10−13−8
Other comprehensive income0000000000−1000000000
Total comprehensive income547320−4−10−4133310−14−7−10−13−8
Net margin4.0%4.3%5.5%2.7%2.1%0.7%−4.8%−10.9%−4.4%0.5%3.5%3.5%3.4%1.6%0.2%−23.9%−14.6%−16.7%−19.4%−13.2%
Earnings per share₹2.86₹2.54₹4.23₹1.92₹1.41₹0.27−₹2.77−₹6.02−₹2.25₹0.32₹2.24₹1.70₹1.70₹0.89₹0.20−₹8.67−₹4.58−₹6.18−₹8.25−₹4.77
Earnings per share in rupees, restated for later splits and bonuses.

The quarters either side of a change of basis do not compare. From the quarter to Mar 2022, the company's revenue for the year to Mar 2022, ₹451 Cr, differs from its quarters added, ₹434 Cr.

Filed results, as an XML file each

16 earlier filings